TACC3 Antibodies

Santa Cruz Biotechnology provides a broad selection of TACC3 monoclonal antibodies for investigating TACC3 in cellular processes. TACC3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TACC3, or Transforming Acidic Coiled-Coil Protein 3, is essential for microtubule stabilization and spindle assembly during cell division. TACC3 maintains genomic stability through its interaction with key mitotic regulators. Research has shown TACC3's involvement in various cancer types, highlighting its significance in therapeutic development. Scientists studying TACC3 can gain valuable insights into cellular division mechanisms and cancer progression. Investigating TACC3 expression patterns helps reveal its role in normal development and disease states. Understanding TACC3 regulation contributes to identifying new therapeutic targets in cancer treatment. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TACC3's role in cancer biology and cell division mechanisms.